EKS-HOS-00051
Eukaryotic Protein Kinase & Protein Phosphatase Database
TagContent
EKPD IDEKS-HOS-00051
Classification
Group/FamilyScoreE-ValueStartEndDomain Length
TKL/RAF414.31.3E-123134391258
StatusReviewed
Ensembl ProteinENSP00000441186
UniProt AccessionP04049; B0LPH8; B2R5N3; Q15278; Q9UC20;
Protein NameRAF proto-oncogene serine/threonine-protein kinase
Protein Synonyms/Alias Proto-oncogene c-RAF; cRaf; Raf-1;
Gene NameRAF1
Gene Synonyms/Alias RAF1; RAF;
Ensembl Information
Ensembl Gene IDEnsembl Protein IDEnsembl Transcript ID
ENSG00000132155ENSP00000443567ENST00000542177
ENSG00000132155ENSP00000251849ENST00000251849
ENSG00000132155ENSP00000401088ENST00000423275
ENSG00000132155ENSP00000398591ENST00000432427
ENSG00000132155ENSP00000401888ENST00000442415
ENSG00000132155ENSP00000391265ENST00000416093
ENSG00000132155ENSP00000441186ENST00000534997
OrganismHomo sapiens
Functional DescriptionSerine/threonine-protein kinase that acts as aregulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2- antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation.
Protein Length433
Protein Sequence
(FASTA)
MCVDWSNIRQ LFSQHRYSTP HAFTFNTSSP SSEGSLSQRQ RSTSTPNVHM VSTTLPVDSR 60
MIEDAIRSHS ESASPSALSS SPNNLSPTGW SQPKTPVPAQ RERAPVSGTQ EKNKIRPRGQ 120
RDSSYYWEIE ASEVMLSTRI GSGSFGTVYK GKWHGDVAVK ILKVVDPTPE QFQAFRNEVA 180
VLRKTRHVNI LLFMGYMTKD NLAIVTQWCE GSSLYKHLHV QETKFQMFQL IDIARQTAQG 240
MDYLHAKNII HRDMKSNNIF LHEGLTVKIG DFGLATVKSR WSGSQQVEQP TGSVLWMAPE 300
VIRMQDNNPF SFQSDVYSYG IVLYELMTGE LPYSHINNRD QIIFMVGRGY ASPDLSKLYK 360
NCPKAMKRLV ADCVKKVKEE RPLFPQILSS IELLQHSLPK INRSASEPSL HRAAHTEDIN 420
ACTLTTSPRL PVF 433
Nucleotide Sequence
(FASTA)
ATGTGTGTGG ACTGGAGTAA CATCAGACAA CTCTTTTCTC AGCACAGATA TTCTACACCT 60
CACGCCTTCA CCTTTAACAC CTCCAGTCCC TCATCTGAAG GTTCCCTCTC CCAGAGGCAG 120
AGGTCGACAT CCACACCTAA TGTCCACATG GTCAGCACCA CCCTGCCTGT GGACAGCAGG 180
ATGATTGAGG ATGCAATTCG AAGTCACAGC GAATCAGCCT CACCTTCAGC CCTGTCCAGT 240
AGCCCCAACA ATCTGAGCCC AACAGGCTGG TCACAGCCGA AAACCCCCGT GCCAGCACAA 300
AGAGAGCGGG CACCAGTATC TGGGACCCAG GAGAAAAACA AAATTAGGCC TCGTGGACAG 360
AGAGATTCAA GCTATTATTG GGAAATAGAA GCCAGTGAAG TGATGCTGTC CACTCGGATT 420
GGGTCAGGCT CTTTTGGAAC TGTTTATAAG GGTAAATGGC ACGGAGATGT TGCAGTAAAG 480
ATCCTAAAGG TTGTCGACCC AACCCCAGAG CAATTCCAGG CCTTCAGGAA TGAGGTGGCT 540
GTTCTGCGCA AAACACGGCA TGTGAACATT CTGCTTTTCA TGGGGTACAT GACAAAGGAC 600
AACCTGGCAA TTGTGACCCA GTGGTGCGAG GGCAGCAGCC TCTACAAACA CCTGCATGTC 660
CAGGAGACCA AGTTTCAGAT GTTCCAGCTA ATTGACATTG CCCGGCAGAC GGCTCAGGGA 720
ATGGACTATT TGCATGCAAA GAACATCATC CATAGAGACA TGAAATCCAA CAATATATTT 780
CTCCATGAAG GCTTAACAGT GAAAATTGGA GATTTTGGTT TGGCAACAGT AAAGTCACGC 840
TGGAGTGGTT CTCAGCAGGT TGAACAACCT ACTGGCTCTG TCCTCTGGAT GGCCCCAGAG 900
GTGATCCGAA TGCAGGATAA CAACCCATTC AGTTTCCAGT CGGATGTCTA CTCCTATGGC 960
ATCGTATTGT ATGAACTGAT GACGGGGGAG CTTCCTTATT CTCACATCAA CAACCGAGAT 1020
CAGATCATCT TCATGGTGGG CCGAGGATAT GCCTCCCCAG ATCTTAGTAA GCTATATAAG 1080
AACTGCCCCA AAGCAATGAA GAGGCTGGTA GCTGACTGTG TGAAGAAAGT AAAGGAAGAG 1140
AGGCCTCTTT TTCCCCAGAT CCTGTCTTCC ATTGAGCTGC TCCAACACTC TCTACCGAAG 1200
ATCAACCGGA GCGCTTCCGA GCCATCCTTG CATCGGGCAG CCCACACTGA GGATATCAAT 1260
GCTTGCACGC TGACCACGTC CCCGAGGCTG CCTGTCTTCT AG 1302
Domain Profile
S: 1     velaekiGsGrfGtvyrgkwhGdvavkllnveelseeqleaFkkevaaykktRhenivLF  60
         v+l+++iGsG+fGtvy+gkwhGdvavk+l+v ++++eq++aF++eva+++ktRh+ni+LF
Q: 134   VMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLF  193
         57899*******************************************************
S: 61    mGyvskpelaivtslckgssLykllheqetkldlaklidiarqiaqgmdYLhakkilhkD  120
         mGy++k++laivt++c+gssLyk+lh+qetk+++ +lidiarq+aqgmdYLhak+i+h+D
Q: 194   MGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRD  253
         ************************************************************
S: 121   lksknilleeglkvvitDFgllsvkrllsgrrekqleipkgwilylapeviralsidleq  180
         +ks+ni+l+egl+v+i+DFgl++vk+++sg  ++q+e+p+g++l++apevir+      q
Q: 254   MKSNNIFLHEGLTVKIGDFGLATVKSRWSG--SQQVEQPTGSVLWMAPEVIRM------Q  305
         ******************************..*********************......*
S: 181   delpfskesDvyafGivlyellarelpyke.esadqilfavgrG.lkpdlskvksklpke  238
         d++pfs++sDvy++Givlyel+++elpy++ +++dqi+f+vgrG ++pdlsk+++++pk+
Q: 306   DNNPFSFQSDVYSYGIVLYELMTGELPYSHiNNRDQIIFMVGRGyASPDLSKLYKNCPKA  365
         ************************************************************
S: 239   lkellleClkfekeeRPlftqilkkl  264
         +k+l+++C+k+ keeRPlf+qil+++
Q: 366   MKRLVADCVKKVKEERPLFPQILSSI  391
         **********************9875
Domain Sequence
(FASTA)
VMLSTRIGSG SFGTVYKGKW HGDVAVKILK VVDPTPEQFQ AFRNEVAVLR KTRHVNILLF 60
MGYMTKDNLA IVTQWCEGSS LYKHLHVQET KFQMFQLIDI ARQTAQGMDY LHAKNIIHRD 120
MKSNNIFLHE GLTVKIGDFG LATVKSRWSG SQQVEQPTGS VLWMAPEVIR MQDNNPFSFQ 180
SDVYSYGIVL YELMTGELPY SHINNRDQII FMVGRGYASP DLSKLYKNCP KAMKRLVADC 240
VKKVKEERPL FPQILSSI 258
Keyword3D-structure; Alternative splicing; ATP-binding; Cell membrane; Complete proteome; Cytoplasm; Deafness; Direct protein sequencing; Disease mutation; Kinase; Membrane; Metal-binding; Methylation; Mitochondrion; Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism; Proto-oncogene; Reference proteome; Serine/threonine-protein kinase; Transferase; Zinc; Zinc-finger.
Sequence SourceEnsembl
Orthology
Ortholog group
Ailuropoda melanoleuca"; ?>Anolis carolinensis"; ?>Callithrix jacchus"; ?>Canis familiaris"; ?>Cavia porcellus"; ?>Equus caballus"; ?>Felis catus"; ?>Gallus gallus"; ?>Gasterosteus aculeatus"; ?>Gorilla gorilla"; ?>Ictidomys tridecemlineatus"; ?>Latimeria chalumnae"; ?>Loxodonta africana"; ?>Macaca mulatta"; ?>Meleagris gallopavo"; ?>Monodelphis domestica"; ?>Mus musculus"; ?>Mustela putorius furo"; ?>Myotis lucifugus"; ?>Nomascus leucogenys"; ?>Ochotona princeps"; ?>Oryctolagus cuniculus"; ?>Oryzias latipes"; ?>Otolemur garnettii"; ?>Pan troglodytes"; ?>Pelodiscus sinensis"; ?>Pongo abelii"; ?>Procavia capensis"; ?>Rattus norvegicus"; ?>Sarcophilus harrisii"; ?>Tetraodon nigroviridis"; ?>Xiphophorus maculatus"; ?>
EKS-AIM-00047
EKS-ANC-00042
EKS-CAJ-00050
EKS-CAF-00051
EKS-CAP-00051
EKS-EQC-00049
EKS-FEC-00049
EKS-GAG-00042
EKS-GAA-00068
EKS-GOG-00050
EKS-ICT-00048
EKS-LAC-00054
EKS-LOA-00050
EKS-MAM-00049
EKS-MEG-00040
EKS-MOD-00049
EKS-MUM-00051
EKS-MUP-00053
EKS-MYL-00053
EKS-NOL-00049
EKS-OCP-00036
EKS-ORC-00047
EKS-ORL-00067
EKS-OTG-00054
EKS-PAT-00047
EKS-PES-00046
EKS-POA-00048
EKS-PRC-00035
EKS-RAN-00050
EKS-SAH-00048
EKS-TEN-00074
EKS-XIM-00068
Gene Ontology
GO:0005829; C:cytosol
GO:0005741; C:mitochondrial outer membrane
GO:0005634; C:nucleus
GO:0005886; C:plasma membrane
GO:0031143; C:pseudopodium
GO:0005524; F:ATP binding
GO:0004709; F:MAP kinase kinase kinase activity
GO:0046872; F:metal ion binding
GO:0004674; F:protein serine/threonine kinase activity
GO:0007190; P:activation of adenylate cyclase activity
GO:0000186; P:activation of MAPKK activity
GO:0007411; P:axon guidance
GO:0008283; P:cell proliferation
GO:0007010; P:cytoskeleton organization
GO:0007173; P:epidermal growth factor receptor signaling pathway
GO:0008543; P:fibroblast growth factor receptor signaling pathway
GO:0007507; P:heart development
GO:0008286; P:insulin receptor signaling pathway
GO:0000165; P:MAPK cascade
GO:0043066; P:negative regulation of apoptotic process
GO:0008285; P:negative regulation of cell proliferation
GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process
GO:0031333; P:negative regulation of protein complex assembly
GO:0048011; P:nerve growth factor receptor signaling pathway
GO:0030168; P:platelet activation
GO:0033138; P:positive regulation of peptidyl-serine phosphorylation
GO:0007265; P:Ras protein signal transduction
GO:0045595; P:regulation of cell differentiation
GO:2000145; P:regulation of cell motility
GO:0035023; P:regulation of Rho protein signal transduction
GO:0001666; P:response to hypoxia
GO:0007268; P:synaptic transmission
KEGG
hsa:5894;
InterPros
IPR020454; DAG/PE-bd.
IPR011009; Kinase-like_dom.
IPR002219; Prot_Kinase_C-like_PE/DAG-bd.
IPR000719; Prot_kinase_cat_dom.
IPR017441; Protein_kinase_ATP_BS.
IPR003116; Raf-like_ras-bd.
IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
IPR008271; Ser/Thr_kinase_AS.
Pfam
PF00130; C1_1; 1.
PF07714; Pkinase_Tyr; 1.
PF02196; RBD; 1.
SMARTs
SM00109; C1; 1.
SM00455; RBD; 1.
Prosites
PS00107; PROTEIN_KINASE_ATP; 1.
PS50011; PROTEIN_KINASE_DOM; 1.
PS00108; PROTEIN_KINASE_ST; 1.
PS50898; RBD; 1.
PS00479; ZF_DAG_PE_1; 1.
PS50081; ZF_DAG_PE_2; 1.
Prints
PR00008; DAGPEDOMAIN.
Created Date20-Feb-2013